Who invested in Theranostics Health?
Theranostics Health's investors include Maryland Venture Fund.

United States · Funded startup
7 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Theranostics Health and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$5.0Mraised across 7 rounds since 2011, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $300K sold, first sale Jan 2015
No investor was named in the report.
From a historical funding recordSEC filing: $405K sold, first sale Aug 2014
No investor was named in the report.
From a historical funding recordSEC filing: $200K sold, first sale Mar 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.1M sold, first sale Jul 2012
No investor was named in the report.
Reported by sec.govSEC filing: $530K sold, first sale Mar 2011
No investor was named in the report.
Reported by sec.govSEC filing: $515K sold, first sale Mar 2011
Theranostics Health filed 11 raises, $7.2M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 2 on the team.
On the board, as filediBarry S StrauchKevin G QuinnMitchell P Cybulski
Theranostics Health's investors include Maryland Venture Fund.
Theranostics Health has raised $5.0M across 7 rounds since 2011.
Theranostics Health's most recent round was a Debt of $300K in Jan 2015.
Theranostics Health's largest round on record is $1.5M (Venture), in Dec 2012.
Theranostics Health's first round on record, in Dec 2012, was backed by Maryland Venture Fund.
Theranostics Health's latest named round is a Debt, in Jan 2015.
Theranostics Health is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.